151 related articles for article (PubMed ID: 1677368)
1. Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.
Gollub SB; Elkayam U; Young JB; Miller LW; Haffey KA
J Am Coll Cardiol; 1991 Aug; 18(2):383-90. PubMed ID: 1677368
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours' duration for severe congestive heart failure.
Gollub SB; Emmot WW; Johnson DE; Sights KA; Wilson DB; Vacek JL; Hassanein K
Am J Cardiol; 1988 Aug; 62(5):83C-88C. PubMed ID: 3407599
[TBL] [Abstract][Full Text] [Related]
3. Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study.
Asanoi H; Sasayama S; Sakurai T; Lee JD; Kinoshita M; Ishimura T; Yoshikawa J; Mitsudo K; Sato H; Morioka S
Cardiovasc Drugs Ther; 1995 Dec; 9(6):791-7. PubMed ID: 8850384
[TBL] [Abstract][Full Text] [Related]
4. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
Santman FW
J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
[TBL] [Abstract][Full Text] [Related]
5. [Dopexamine: a new dopaminergic agonist].
Perrin G; Papazian L; Martin C
Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
[TBL] [Abstract][Full Text] [Related]
7. Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
Murphy JJ; Hampton JR
Br Heart J; 1988 Jul; 60(1):45-9. PubMed ID: 2900644
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
Baumann G; Felix SB; Filcek SA
Am J Cardiol; 1990 Mar; 65(11):748-54. PubMed ID: 1969223
[TBL] [Abstract][Full Text] [Related]
9. Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
De Marco T; Kwasman M; Lau D; Chatterjee K
Am J Cardiol; 1988 Aug; 62(5):57C-62C. PubMed ID: 3407596
[TBL] [Abstract][Full Text] [Related]
10. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
[TBL] [Abstract][Full Text] [Related]
11. Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure.
Vincent JL; Reuse C; Kahn RJ
Chest; 1989 Dec; 96(6):1233-6. PubMed ID: 2573484
[TBL] [Abstract][Full Text] [Related]
12. The use of dopexamine after cardiac surgery: acute and long-term effects in patients with impaired cardiac function.
Friedel N; Wenzel R; Matheis G; Hetzer R
Thorac Cardiovasc Surg; 1992 Dec; 40(6):378-81. PubMed ID: 1363257
[TBL] [Abstract][Full Text] [Related]
13. Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting.
Flynn MJ; Winter DC; Breen P; O'Sullivan G; Shorten G; O'Connell D; O'Donnell A; Aherne T
Eur J Cardiothorac Surg; 2003 Oct; 24(4):547-51. PubMed ID: 14500073
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
Tan LB; Littler WA; Murray RG
Int J Cardiol; 1991 Feb; 30(2):203-8. PubMed ID: 2010243
[TBL] [Abstract][Full Text] [Related]
15. Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery.
Sherry E; Tooley MA; Bolsin SN; Monk CR; Willcox J
Eur J Anaesthesiol; 1997 Mar; 14(2):184-9. PubMed ID: 9088818
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
Svenson G; Strandberg LE; Lindvall B; Erhardt L
Br Heart J; 1988 Dec; 60(6):489-96. PubMed ID: 3224052
[TBL] [Abstract][Full Text] [Related]
17. Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
Svensson G; Sjögren A; Erhardt L
Eur Heart J; 1986 Aug; 7(8):697-703. PubMed ID: 2876894
[TBL] [Abstract][Full Text] [Related]
18. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Jaski BE; Peters C
Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
[TBL] [Abstract][Full Text] [Related]
19. Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs.
Taylor BJ; Rogers BW; Sziszak TL; Sziszak TJ
Crit Care Med; 1993 May; 21(5):733-9. PubMed ID: 8386999
[TBL] [Abstract][Full Text] [Related]
20. Clinical development of dopexamine hydrochloride (Dopacard) and an overview of its hemodynamic effects.
Foulds RA
Am J Cardiol; 1988 Aug; 62(5):41C-45C. PubMed ID: 3044060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
